Early impacts of the 'National Suicide Prevention Trial' on trends in suicide and hospital admissions for self-harm in Australia.

This article evaluates the early population-level impact of the Australian Government’s National Suicide Prevention Trial (NSPT), launched in 2016 across 12 Primary Health Network (PHN) sites covering approximately 8 million people, on suicide rates and hospital admissions for self-harm. Using a difference-in-difference analysis comparing NSPT areas to control PHNs without formal trial activities from 2010 to 2020, the study found no substantial overall reductions in suicide or self-harm rates attributable to the NSPT during the first four years of implementation. Some relative decreases in hospital admissions for self-harm were observed among males, individuals aged 55–64 years, residents of high socio-economic status areas, and metropolitan and remote regions, but these effects were modest. The authors note that the limited early impact may reflect the time needed for prevention activities to take effect, the nature and scale of interventions, and potential influences of concurrent suicide prevention efforts in control areas, emphasizing the need for continued monitoring over the next several years to assess longer-term outcomes.